| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 | 2019 | 526 | 1.69 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2019 | 1573 | 0.78 | Why? |
| Hepatic Encephalopathy | 1 | 2017 | 88 | 0.66 | Why? |
| Hypertension, Portal | 1 | 2017 | 73 | 0.64 | Why? |
| Esophageal and Gastric Varices | 1 | 2017 | 117 | 0.60 | Why? |
| Liver Cirrhosis | 2 | 2017 | 1810 | 0.60 | Why? |
| Low Back Pain | 1 | 2018 | 190 | 0.58 | Why? |
| Healthy Lifestyle | 1 | 2018 | 447 | 0.52 | Why? |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2019 | 82 | 0.52 | Why? |
| Blood Pressure | 3 | 2019 | 2198 | 0.49 | Why? |
| Pediatric Obesity | 1 | 2018 | 492 | 0.49 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.48 | Why? |
| Risk Reduction Behavior | 1 | 2018 | 946 | 0.43 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2017 | 669 | 0.43 | Why? |
| Chronic Pain | 1 | 2018 | 736 | 0.39 | Why? |
| Proportional Hazards Models | 4 | 2021 | 6543 | 0.39 | Why? |
| Neurotoxicity Syndromes | 2 | 2019 | 124 | 0.35 | Why? |
| Hematopoietic Stem Cells | 3 | 2019 | 321 | 0.34 | Why? |
| Cyclophosphamide | 2 | 2019 | 387 | 0.32 | Why? |
| Peripheral Nervous System Diseases | 2 | 2019 | 193 | 0.31 | Why? |
| Hypertension | 4 | 2019 | 8895 | 0.28 | Why? |
| Disease-Free Survival | 5 | 2019 | 1654 | 0.28 | Why? |
| HLA Antigens | 1 | 2010 | 830 | 0.28 | Why? |
| Genetic Therapy | 2 | 2019 | 409 | 0.27 | Why? |
| Recurrence | 7 | 2019 | 3675 | 0.26 | Why? |
| Hematopoietic Stem Cell Transplantation | 4 | 2019 | 2426 | 0.25 | Why? |
| Daunorubicin | 2 | 2019 | 33 | 0.25 | Why? |
| Asparaginase | 2 | 2019 | 26 | 0.24 | Why? |
| Continuous Positive Airway Pressure | 2 | 2021 | 1187 | 0.23 | Why? |
| Cancer Survivors | 2 | 2019 | 588 | 0.22 | Why? |
| Vincristine | 2 | 2018 | 89 | 0.22 | Why? |
| Neoplasm, Residual | 5 | 2019 | 147 | 0.21 | Why? |
| Delirium | 2 | 2021 | 1061 | 0.21 | Why? |
| Cytarabine | 2 | 2019 | 64 | 0.21 | Why? |
| Algorithms | 3 | 2018 | 7346 | 0.21 | Why? |
| Myeloid-Lymphoid Leukemia Protein | 1 | 2019 | 6 | 0.21 | Why? |
| Mitoxantrone | 1 | 2019 | 30 | 0.21 | Why? |
| Multigene Family | 2 | 2020 | 377 | 0.20 | Why? |
| Cystadenofibroma | 1 | 2019 | 1 | 0.20 | Why? |
| Gene Rearrangement | 1 | 2019 | 84 | 0.20 | Why? |
| Asparagine | 1 | 2019 | 83 | 0.19 | Why? |
| Wiskott-Aldrich Syndrome | 1 | 2019 | 41 | 0.19 | Why? |
| Germ-Line Mutation | 1 | 2019 | 86 | 0.19 | Why? |
| Gene Deletion | 2 | 2018 | 430 | 0.19 | Why? |
| Ductus Arteriosus | 1 | 2018 | 4 | 0.19 | Why? |
| Mercaptopurine | 1 | 2019 | 68 | 0.19 | Why? |
| Tocolytic Agents | 1 | 2018 | 23 | 0.19 | Why? |
| Diet, Carbohydrate Loading | 1 | 2018 | 2 | 0.19 | Why? |
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 82 | 0.19 | Why? |
| Carcinoma, Large Cell | 1 | 2018 | 13 | 0.19 | Why? |
| Sural Nerve | 1 | 2018 | 8 | 0.19 | Why? |
| Ikaros Transcription Factor | 1 | 2018 | 10 | 0.19 | Why? |
| Organ Sparing Treatments | 1 | 2019 | 91 | 0.19 | Why? |
| Etoposide | 1 | 2019 | 115 | 0.18 | Why? |
| Indomethacin | 1 | 2018 | 47 | 0.18 | Why? |
| Glycogen Storage Disease Type II | 1 | 2018 | 26 | 0.18 | Why? |
| Chromosomes, Human, Pair 3 | 1 | 2020 | 195 | 0.18 | Why? |
| alpha-Glucosidases | 1 | 2018 | 39 | 0.18 | Why? |
| Blood Pressure Monitoring, Ambulatory | 2 | 2019 | 341 | 0.18 | Why? |
| PTEN Phosphohydrolase | 1 | 2018 | 70 | 0.18 | Why? |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 31 | 0.18 | Why? |
| Mucopolysaccharidosis I | 1 | 2017 | 9 | 0.18 | Why? |
| Pulse Wave Analysis | 1 | 2019 | 221 | 0.18 | Why? |
| Osteonecrosis | 1 | 2018 | 55 | 0.18 | Why? |
| Transcriptional Regulator ERG | 1 | 2017 | 19 | 0.18 | Why? |
| RNA, Small Nucleolar | 1 | 2017 | 13 | 0.18 | Why? |
| Portal Pressure | 1 | 2017 | 13 | 0.18 | Why? |
| Fertility Preservation | 1 | 2019 | 121 | 0.17 | Why? |
| Lentivirus | 1 | 2019 | 310 | 0.17 | Why? |
| Ascites | 1 | 2017 | 65 | 0.17 | Why? |
| Pulmonary Gas Exchange | 1 | 2020 | 414 | 0.17 | Why? |
| Angioplasty | 1 | 2018 | 106 | 0.17 | Why? |
| Italy | 16 | 2021 | 38444 | 0.16 | Why? |
| Prednisone | 2 | 2018 | 652 | 0.16 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2019 | 219 | 0.16 | Why? |
| Bone and Bones | 1 | 2019 | 235 | 0.16 | Why? |
| Lost to Follow-Up | 1 | 2016 | 79 | 0.16 | Why? |
| Cord Blood Stem Cell Transplantation | 1 | 2017 | 143 | 0.16 | Why? |
| Patients' Rooms | 1 | 2021 | 675 | 0.16 | Why? |
| Child, Preschool | 15 | 2019 | 36283 | 0.15 | Why? |
| Uric Acid | 1 | 2019 | 285 | 0.15 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.15 | Why? |
| Jaundice | 1 | 2017 | 114 | 0.15 | Why? |
| Disease Progression | 4 | 2019 | 13580 | 0.15 | Why? |
| Child | 20 | 2020 | 70012 | 0.15 | Why? |
| Vascular Stiffness | 1 | 2019 | 264 | 0.15 | Why? |
| beta-Thalassemia | 1 | 2019 | 200 | 0.15 | Why? |
| Treatment Outcome | 11 | 2021 | 51732 | 0.15 | Why? |
| Doxorubicin | 1 | 2017 | 313 | 0.15 | Why? |
| Biomedical Research | 1 | 2016 | 5270 | 0.14 | Why? |
| Remission Induction | 3 | 2017 | 950 | 0.14 | Why? |
| Fertility | 1 | 2019 | 367 | 0.14 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.14 | Why? |
| Adolescent | 18 | 2021 | 86841 | 0.14 | Why? |
| Polyethylene Glycols | 1 | 2019 | 574 | 0.13 | Why? |
| Ovarian Neoplasms | 1 | 2019 | 465 | 0.13 | Why? |
| Patient Reported Outcome Measures | 1 | 2019 | 912 | 0.12 | Why? |
| Nomograms | 1 | 2019 | 790 | 0.12 | Why? |
| Male | 35 | 2021 | 367725 | 0.12 | Why? |
| Female | 38 | 2021 | 380317 | 0.12 | Why? |
| Oncologists | 1 | 2019 | 877 | 0.12 | Why? |
| Genetic Vectors | 1 | 2019 | 1600 | 0.11 | Why? |
| Infant | 10 | 2019 | 30274 | 0.11 | Why? |
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 529 | 0.11 | Why? |
| Prognosis | 7 | 2019 | 32490 | 0.11 | Why? |
| ABO Blood-Group System | 1 | 2020 | 995 | 0.11 | Why? |
| Noninvasive Ventilation | 2 | 2021 | 2329 | 0.11 | Why? |
| Humans | 47 | 2021 | 930598 | 0.11 | Why? |
| Antineoplastic Agents | 3 | 2018 | 3550 | 0.11 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.11 | Why? |
| Health Services for the Aged | 1 | 2018 | 602 | 0.11 | Why? |
| Time Factors | 6 | 2018 | 31397 | 0.10 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.10 | Why? |
| Activities of Daily Living | 1 | 2019 | 1530 | 0.10 | Why? |
| Renal Insufficiency | 1 | 2017 | 810 | 0.10 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.10 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.10 | Why? |
| Blood Transfusion | 1 | 2019 | 1399 | 0.09 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.09 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2016 | 676 | 0.09 | Why? |
| Public Policy | 1 | 2021 | 1894 | 0.09 | Why? |
| Prone Position | 1 | 2020 | 1861 | 0.09 | Why? |
| Survival Rate | 3 | 2019 | 9206 | 0.09 | Why? |
| Frailty | 1 | 2020 | 1432 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.08 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.08 | Why? |
| Reproducibility of Results | 3 | 2020 | 11304 | 0.08 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.08 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.08 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.07 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.07 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.07 | Why? |
| Risk Assessment | 3 | 2017 | 25439 | 0.07 | Why? |
| Follow-Up Studies | 5 | 2019 | 17020 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2018 | 1884 | 0.07 | Why? |
| Software | 1 | 2016 | 2501 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Registries | 3 | 2019 | 12327 | 0.07 | Why? |
| Infant, Newborn | 3 | 2019 | 23105 | 0.06 | Why? |
| Exercise | 2 | 2018 | 6771 | 0.06 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Adult | 13 | 2021 | 244371 | 0.06 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.05 | Why? |
| Feasibility Studies | 2 | 2021 | 3467 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.05 | Why? |
| Aged | 14 | 2021 | 215776 | 0.05 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.05 | Why? |
| Computer Simulation | 1 | 2016 | 4982 | 0.05 | Why? |
| Protein Kinase Inhibitors | 1 | 2010 | 1585 | 0.05 | Why? |
| Chromosomes, Human, Pair 9 | 1 | 2020 | 196 | 0.05 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.05 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.05 | Why? |
| Wiskott-Aldrich Syndrome Protein | 1 | 2019 | 37 | 0.05 | Why? |
| Elective Surgical Procedures | 1 | 2018 | 5338 | 0.05 | Why? |
| Neoplasms | 2 | 2019 | 17251 | 0.05 | Why? |
| Salpingo-oophorectomy | 1 | 2019 | 59 | 0.05 | Why? |
| Ovariectomy | 1 | 2019 | 53 | 0.05 | Why? |
| Multivariate Analysis | 1 | 2010 | 5440 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.05 | Why? |
| Research Design | 1 | 2016 | 5830 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2018 | 10 | 0.05 | Why? |
| PAX5 Transcription Factor | 1 | 2018 | 5 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| Sex Characteristics | 1 | 2007 | 1120 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.05 | Why? |
| Odds Ratio | 1 | 2010 | 5861 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Dysostoses | 1 | 2017 | 3 | 0.05 | Why? |
| Organoplatinum Compounds | 1 | 2018 | 76 | 0.05 | Why? |
| Receptor, PAR-1 | 1 | 2018 | 24 | 0.05 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.05 | Why? |
| Chromosomes, Human, Pair 15 | 1 | 2017 | 13 | 0.04 | Why? |
| X-Ray Microtomography | 1 | 2017 | 115 | 0.04 | Why? |
| Czech Republic | 1 | 2019 | 307 | 0.04 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.04 | Why? |
| Prader-Willi Syndrome | 1 | 2017 | 31 | 0.04 | Why? |
| Chromosomes, Human, Pair 21 | 1 | 2017 | 90 | 0.04 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2018 | 107 | 0.04 | Why? |
| Chromosome Aberrations | 1 | 2017 | 54 | 0.04 | Why? |
| Heart Rate | 1 | 2007 | 1527 | 0.04 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.04 | Why? |
| Transplantation Conditioning | 1 | 2019 | 323 | 0.04 | Why? |
| Age of Onset | 1 | 2019 | 557 | 0.04 | Why? |
| Respiratory Mechanics | 1 | 2020 | 585 | 0.04 | Why? |
| Quantitative Trait Loci | 1 | 2017 | 340 | 0.04 | Why? |
| Cannula | 1 | 2021 | 750 | 0.04 | Why? |
| Blood Pressure Determination | 1 | 2019 | 450 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 11367 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2021 | 243684 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Germany | 2 | 2021 | 9196 | 0.03 | Why? |
| Austria | 1 | 2019 | 1259 | 0.03 | Why? |
| Patient Outcome Assessment | 1 | 2018 | 707 | 0.03 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.03 | Why? |
| Probability | 1 | 2018 | 923 | 0.03 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Mammography | 1 | 2017 | 410 | 0.03 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Leukemia | 1 | 2018 | 598 | 0.03 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Electrocardiography | 1 | 2007 | 3957 | 0.03 | Why? |
| Stem Cell Transplantation | 1 | 2018 | 531 | 0.03 | Why? |
| Spain | 2 | 2021 | 15545 | 0.03 | Why? |
| Geriatric Assessment | 1 | 2020 | 1372 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.03 | Why? |
| Drug Monitoring | 1 | 2019 | 1408 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Methotrexate | 1 | 2014 | 471 | 0.03 | Why? |
| HIV Infections | 1 | 2016 | 11620 | 0.02 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.02 | Why? |
| Insulin | 1 | 2018 | 1316 | 0.02 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Steroids | 1 | 2014 | 904 | 0.02 | Why? |
| Mutation | 2 | 2019 | 12376 | 0.02 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.02 | Why? |
| Laparoscopy | 1 | 2019 | 1532 | 0.02 | Why? |
| Neoplasm Recurrence, Local | 1 | 2014 | 1063 | 0.02 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Ventricular Function | 1 | 2007 | 93 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| England | 1 | 2018 | 5116 | 0.02 | Why? |
| Rest | 1 | 2007 | 188 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.02 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2019 | 4418 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.02 | Why? |
| Idarubicin | 1 | 2002 | 15 | 0.02 | Why? |
| Pediatrics | 1 | 2019 | 2969 | 0.02 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2019 | 6670 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |